Job Title: Principal Firmware Engineer
Company: Adraxe
Job Type: Full-Time
Location: Plymouth, MN (Hybrid)
Adraxe Corporation is an innovative medical device startup focused on the design, development, and launch of breakthrough, minimally invasive neuromodulation solutions to address unmet patient needs. The results from the first clinical epilepsy patients are encouraging and we are at the important stage of hiring key personnel, to accelerate our progress and starting our full product and clinical development. Our goal is to revolutionize neurological care with life-compatible, closed-loop neuromodulation therapies, starting with epilepsy.
About the role
This Principal Embedded Software Engineer will lead the design and development of safety-critical firmware for advanced implantable neurostimulator systems. The person in this role will architect, implement, and verify embedded software that drives closed-loop neural stimulation and sensing technologies, enabling life-changing therapy for patients with epilepsy.
As a senior technical leader, you will work closely with cross-functional teams—including systems, hardware, firmware, and clinical engineering—to deliver innovative and compliant software solutions that meet stringent regulatory and performance standards.
This position will report directly to the VP and Chief engineer and will have significant input into Adraxe strategy, planning, and operations.
What you'll do
Qualifications
Preferred Qualifications
Physical and Other Requirements

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today.
Connect with us:
Join Our Team | https://bit.ly/3bCsXRv
LinkedIn | https://bit.ly/3PfifOL
Twitter | https://bit.ly/3PfifOL
Instagram | https://bit.ly/3bMaYrW
Facebook | https://bit.ly/3JRc2av
Clinical Trials | https://bit.ly/3A8QPWm
Our site | https://blackrockneurotech.com
Additional information:
As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications.
Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023.
Join us in changing lives today.